Enrollment Complete for Phase 4 Trial Assessing H.P. Acthar Gel in Rheumatoid Arthritis
News
The phase 4 study evaluating H.P. Acthar Gel in patients with rheumatoid arthritis exceeded its enrollment goal, Mallinckrodt Pharmaceuticals announced. The ongoing study enrolled more than 230 adult patients over ... Read more